Introduction
The natural product featuring a molecular ion peak at m/z 443.In real terms, 1681 and containing a 10‑membered epoxide ring has attracted considerable attention from chemists, pharmacologists, and botanists. This unique structure combines an epoxidized macrolactone with a complex array of functional groups, giving rise to remarkable biological activities and a challenging synthetic route. Understanding its chemical characteristics, biosynthetic origin, analytical detection, and potential applications provides valuable insight into both natural product chemistry and drug discovery pipelines. Throughout this article we will explore the key aspects of this intriguing molecule, from its structural elucidation to its role in modern research Simple, but easy to overlook..
Chemical Structure and Molecular Features
Molecular Formula and Mass
The observed m/z 443.1681 corresponds to the protonated molecular ion [M+H]⁺ of the compound, indicating a neutral molecular weight of 442.So 1554 Da. High‑resolution mass spectrometry (HR‑MS) reveals a formula of C₂₄H₃₈O₆, which accounts for 24 carbon atoms, 38 hydrogens, and six oxygens. The presence of six oxygens is consistent with an epoxide (a three‑membered oxirane), additional carbonyl or hydroxyl functionalities, and possibly an ether linkage within the macrocyclic framework Worth keeping that in mind..
Epoxide in a Ten‑Membered Ring
The defining structural motif is a 10‑membered cyclic ether bearing an epoxide. Think about it: this macrolide differs from the more common 12‑ or 14‑membered lactones found in many natural products. The ring strain introduced by the epoxide can influence reactivity, conformation, and interaction with biological targets. Still, nMR spectroscopy (¹H, ¹³C, HSQC, HMBC) typically shows characteristic chemical shifts for the epoxide carbons (δ C ≈ 50–60 ppm) and the macrocyclic protons (δ H ≈ 3. 0–4.Day to day, 5 ppm). The 10‑membered ring adopts a twist‑boat or chair‑like conformation, which is stabilized by intramolecular hydrogen bonding and possible cis‑trans relationships between substituents Simple, but easy to overlook. Which is the point..
Biosynthetic Pathway
Origin in Microbial or Plant Sources
This natural product is isolated primarily from actinomycete strains and certain mycorrhizal fungi, where it is believed to play a defensive role against competing microorganisms. Genomic analysis of the producing organisms often reveals a type I polyketide synthase (PKS) gene cluster responsible for assembling the carbon backbone, followed by tailoring enzymes that introduce the epoxide functionality.
This changes depending on context. Keep that in mind.
Key Enzymatic Steps
- Chain Elongation – The PKS iteratively adds acetyl‑ and propionyl‑CoA units, generating a long‑chain polyketide precursor.
- Cyclization – A macrolactonization step closes the 10‑membered ring, forming the macrocyclic lactone core.
- Epoxidation – An oxidative epoxygenase (often a cytochrome P450 monooxygenase) converts a neighboring double bond into the epoxide, a reaction reminiscent of styrene epoxidation but adapted for aliphatic olefins.
- Further Tailoring – Additional modifications such as hydroxylation, methylation, or acetylation fine‑tune the molecule’s polarity and bioactivity.
The precise order of these steps can vary among species, leading to structural analogs that differ in substitution patterns while retaining the core epoxide‑containing macrocycle.
Analytical Detection and Characterization
Mass Spectrometry
HR‑MS is the primary tool for initial identification. 1681** ion, together with its isotopic pattern, serves as a fingerprint. So the **m/z 443. Tandem MS (MS/MS) often produces diagnostic fragment ions that reveal the location of the epoxide and other functional groups.
Nuclear Magnetic Resonance
A combination of 1D (¹H, ¹³C) and 2D (HSQC, HMBC, COSY) experiments provides detailed connectivity. Key observations include:
- Epoxide carbons: ¹³C shifts around 50–60 ppm.
- Macrocyclic methylene protons: multiplets between 2.0–3.5 ppm.
- Oxygen‑bearing carbons: carbonyl signals near 170–180 ppm.
Chromatographic Separation
High‑performance liquid chromatography (HPLC) coupled with diode‑array detection (DAD) helps isolate the compound from complex extracts. The polarity of the molecule, due to multiple hydroxyl groups, often necessitates reversed‑phase columns with gradient elution using water‑acetonitrile or water‑methanol mixtures.
Biological Activity and Therapeutic Potential
Antimicrobial Properties
Early bioassays demonstrated that the 10‑membered epoxide natural product exhibits potent activity against Gram‑positive bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis. The epoxide moiety is thought to react with nucleophilic residues in bacterial enzymes, disrupting essential metabolic pathways And it works..
Anticancer Activity
In vitro studies have shown cytotoxic effects against several cancer cell lines, including lung adenocarcinoma (A549) and breast carcinoma (MCF‑7). The mechanism may involve induction of apoptosis through oxidative stress or interference with microtubule dynamics, although the exact target remains under investigation.
Neuroprotective Potential
Recent reports suggest that analogs of this scaffold can protect neuronal cells from oxidative damage, opening avenues for treating neurodegenerative diseases. The epoxide’s ability to act as a mild electrophile may enable covalent modulation of key signaling proteins.
Synthetic Strategies
Total Synthesis Challenges
Synthesizing a 10‑membered epoxide macrocycle presents significant ring‑closure and stereochemical challenges. Researchers have employed macrolactonization techniques such as Yamaguchi, Mukaiyama, and Rieche conditions, often using high‑dilution approaches to favor intramolecular cyclization over polymerization.
Key Synthetic Steps
- Construction of the Carbon Backbone – Iterative cross‑coupling (e.g., Suzuki‑Miyaura) builds the carbon chain with precise stereochemistry.
- Epoxidation – m‑CPBA or DIOS (diiodine tetraoxide) can be used to introduce the epoxide with high enantioselectivity when chiral auxiliaries are employed.
- Functional Group Installation – Hydroxy groups are introduced via hydride reductions or nucleophilic substitutions.
- Final Macrolactonization – The macrocyclic lactone is formed under Yamaguchi conditions (2,4,6‑Trichlorobenzoyl chloride, DMAP) to afford the desired 10‑membered ring.
Despite the complexity, total synthesis has provided authentic samples for detailed pharmacological evaluation and enabled the preparation of deuterium‑labeled analogs for metabolic studies Took long enough..
Frequently Asked Questions (FAQ)
What is the significance of the m/z 443.1681 peak?
The m/z 443.1681 corresponds to the protonated molecular ion of the natural product, confirming its molecular weight and enabling identification via high‑resolution mass spectrometry.
Why is the epoxide important?
The epoxide introduces ring strain and electrophilic character, which are crucial for the compound’s biological activity and synthetic reactivity.
How is the 10‑membered ring formed?
The macrocyclic ring arises through intramolecular macrolactonization during biosynthesis or via **
Biosynthetic Considerations
The biosynthetic origin of this macrocycle likely involves a polyketide synthase (PKS) pathway, where iterative condensation of malonyl units generates the carbon backbone. A critical step would be the epoxidation of a precursor alkene, possibly mediated by cytochrome P450 enzymes or flavin-dependent monooxygenases. Understanding these biosynthetic routes could streamline the discovery of related natural products and inform semi-synthetic strategies to access novel analogs with improved pharmacokinetic profiles Most people skip this — try not to..
Challenges and Considerations
While the compound shows promising bioactivity, several hurdles remain. Worth adding: Synthetic scalability is non-trivial due to the ring strain of the 10-membered epoxide and the need for high-dilution conditions in macrolactonization. Here's the thing — additionally, the electrophilic nature of the epoxide may lead to off-target covalent modifications in vivo, necessitating careful assessment of toxicity and selectivity. Metabolic stability is another concern; preliminary studies suggest rapid epoxide hydrolysis, which could be addressed through strategic deuteration or structural modifications to enhance plasma half-life.
Clinical Translation Prospects
If pharmacokinetic and safety profiles are optimized, this scaffold could advance into preclinical trials for oncology and neurodegenerative disease indications. The dual c
